Terbinafine lacquer

Drug Profile

Terbinafine lacquer

Alternative Names: InnoNyx; MycoVa; NM02101; NM100060

Latest Information Update: 11 May 2015

Price : $50

At a glance

  • Originator NexMed
  • Developer Apricus Biosciences; Novartis
  • Class Antifungals; Naphthalenes; Small molecules
  • Mechanism of Action Squalene monooxygenase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Discontinued Onychomycosis

Most Recent Events

  • 15 Mar 2016 Biomarkers information updated
  • 02 Jan 2013 Stellar Pharmaceuticals is now called Tribute Pharmaceuticals Canada
  • 10 Jan 2012 Terbinafine lacquer licensed to Elis Pharmaceuticals in Middle East & Gulf
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top